Adalimumab: Another Medication Related to Osteonecrosis of the Jaws? by Andrea Cassoni, Umberto Romeo, Valentina Terenzi, Marco Della Monaca, Oriana Rajabtork Zadeh, Ingrid Raponi, Maria Teresa Fadda, Antonella Polimeni, Valentino Valentini

“…On August, 2014, a 63-year-old female with a history of idiopathic arthritis treated with medical treatment with Adalimumab from 2010 to 2013 presented referring pain in the right mandible. …”
Get full text

A Meta-Analysis of Adalimumab for Fistula in Crohn’s Disease by Yin-mei Fu, Ming Chen, Ai-jun Liao

“…This study aimed to evaluate the therapeutic value of adalimumab (ADA) for fistula in Crohn’s disease (CD). …”
Get full text

Tuberculosis of the tongue in a patient under treatment with adalimumab by Cintia Mussi Milani, Rafaela Arana, Rafaela Sávio Melzer, Antônio Adilson Soares Lima, Maria Angela Naval Machado, Liliane Roskamp

Subjects: “…adalimumab…”
Get full text

Successful Treatment of Annular Atrophic Lichen Planus With Adalimumab by Joe Khodeir, Paul Ohanian, Marielena Ohanian

Subjects: “…adalimumab…”
Get full text

Adalimumab-induced optic neuropathy in a patient with Behçet’s syndrome by Sofia Miranda, Daniel Calado, Joana Rua, Fernando Salvador

Subjects: “…adalimumab…”
Get full text

Efficacy of Adalimumab in a Girl with Refractory Intestinal Behcet’s Disease by Mariko Kaji, Takayuki Kishi, Takako Miyamae, Satoru Nagata, Hisashi Yamanaka, Satoshi Fujikawa

“…We describe our experience with a juvenile patient who had refractory intestinal Behcet’s disease that responded to adalimumab, a fully humanized antibody against soluble TNF-α and its receptor. …”
Get full text

Acute Pancreatitis: An Unusual Side Effect of Adalimumab in Crohn’s Disease Patient by Walid El Ouardi, Mustapha Benazzouz

“…TNFα inhibitors specially adalimumab is very rarely reported in the literature, primarily through case reports, as a potential cause of acute pancreatitis. …”
Get full text

Size exclusion chromatography as green support for forced degradation study of adalimumab by Kovačić Jelena, Klarić Daniela Amidžić, Turk Nikša, Mornar Ana

Subjects: Get full text

Usefulness of Adalimumab in the Treatment of Refractory Uveitis Associated with Juvenile Idiopathic Arthritis by Carmen García-De-Vicuña, Manuel Díaz-Llopis, David Salom, Rosa Bou, Jesus Díaz-Cascajosa, Miguel Cordero-Coma, Gabriela Ortega, Norberto Ortego-Centeno, Marta Suarez-De-Figueroa, Juan Cruz-Martínez, Alex Fonollosa, Ricardo Blanco, Ángel María García-Aparicio, Jose M. Benítez-Del-Castillo, Jordi Antón

“…To assess the efficacy and safety of adalimumab in patients with juvenile idiopathic arthritis (JIA) and associated refractory uveitis. …”
Get full text

Efficacy and Safety of Adalimumab in Canadian Patients with Moderate to Severe Crohn’s Disease: Results of the Adalimumab in Canadian SubjeCts with ModErate to Severe Crohn’s DiseaSe (ACCESS) Trial by Remo Panaccione, Edward V Loftus, David Binion, Kevin McHugh, Shamsul Alam, Naijun Chen, Benoît Guérette, Parvez Mulani, Jingdong Chao

“…OBJECTIVE: To evaluate open-label adalimumab therapy for clinical effectiveness, fistula healing, patient-reported outcomes and safety in Canadian patients with moderate to severe Crohn’s disease (CD) who were either naive to or previously exposed to antitumour necrosis factor (anti-TNF) therapy.…”
Get full text

Efficacy of adalimumab in pediatric non-infectious uveitis with and without anterior segment inflammation by Chunbo Zhang, Xiaorong Xue, Jinan Xiao, Qiongge Li, Yuyao Zhai, Ying Chen

Subjects: Get full text

Establishment and internal validation of a model to predict the efficacy of Adalimumab in Crohn’s disease by Fang Wang, He Zhou, Yujie Zhang, Yu Da, Tiantian Zhang, Yanting Shi, Tong Wu, Jie Liang

“…Abstract Background: Clinically, the ability to distinguish which Crohn’s disease patients can benefit from Adalimumab is limited. Aims: This study aimed to develop a model for predicting clinical remission probability for Crohn’s disease patients with Adalimumab at 12 weeks. …”
Get full text

Adalimumab‐Induced Cutaneous Lupus Erythematosus: Cases Presenting With Malar Rash and Panniculitis by Parvin Mansouri, Farahnaz Bidari‐Zerehpoosh, Nikoo Mozafari

“…This report presents two cases of cutaneous lupus erythematosus (LE) in women aged 38 and 61 after adalimumab treatment for psoriasis highlighting the importance of recognizing these paradoxical reactions for timely management.…”
Get full text

Drug-Induced Liver Injury Caused by Adalimumab: A Case Report and Review of the Bibliography by Bernardo Frider, Andres Bruno, Marcelo Ponte, Marcelo Amante

“…A new liver biopsy showed portal inflammation with eosinophils and a METAVIR A1 F2. We think that adalimumab appears to be responsible for the liver injury, because of temporal relationship, liver biopsy findings, other clinical conditions being discarded, and the improvement of clinical symptoms and biochemical abnormalities when adalimumab was suspended.…”
Get full text

Effect of Adalimumab on Refractory Arthritis in Juvenile Idiopathic Inflammatory Myopathy with Anti-MDA5 Autoantibody by Takako Miyamae, Takuma Hara, Aki Hanaya, Yumi Tani, Takayuki Kishi, Hisashi Yamanaka

“…PSL was discontinued 10 months after adalimumab initiation; after 9 more months of adalimumab, there were no significant ultrasonography findings. …”
Get full text

A Rare Side Effect due to TNF-Alpha Blocking Agent: Acute Pleuropericarditis with Adalimumab by Hakan Ozkan, Ahmet Seckin Cetinkaya, Tekin Yildiz, Tahsin Bozat

“…There are several side effects reported in patients with adalimumab therapy. Cardiac side effects of adalimumab are rare. …”
Get full text

Adalimumab Induced or Provoked MS in Patient with Autoimmune Uveitis: A Case Report and Review of the Literature by Rana Alnasser Alsukhni, Ziena Jriekh, Yasmin Aboras

“…A 23-year-old male with autoimmune uveitis and a family history of multiple sclerosis (MS) developed two neurological attacks, after Adalimumab infusion, simultaneously with several cerebral lesions on magnetic resonance imaging (MRI). …”
Get full text

Successful treatment of etanercept- and adalimumab-resistant pyoderma gangrenosum with spesolimab, moderate-dose corticosteroids, and minocycline by Hanlin Zhang, Chao Wu, Hongzhong Jin

“…This study explores the potential of spesolimab, an anti-IL-36R antibody, as a therapeutic option for refractory PG.Materials and methods We report a case of a 48-year-old male with refractory PG who failed to respond to etanercept and adalimumab. Upon admission, the patient presented with extensive, painful ulcerations on the trunk and extremities. …”
Get full text

Henoch-Schönlein Purpura with Adalimumab Therapy for Ulcerative Colitis: A Case Report and Review of the Literature by Joseph J. LaConti, Jean A. Donet, Jeong Hee Cho-Vega, Daniel A. Sussman, Dana Ascherman, Amar R. Deshpande

“…We present a case of HSP complicating adalimumab treatment in a patient with ulcerative colitis who had achieved endoscopic remission. …”
Get full text

Adalimumab induced psoriasis in Crohn’s disease and treatment with ustekinumab: case report and special histopathological findings by Fang Qiu, Weiquan Chen, Ying Zhou

Subjects: Get full text